New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 4591 | Deltorphin I | Potent δ agonist |
| 4620 | Olmesartan medoxomil | Selective non-peptide AT1 antagonist; prodrug of Olmesartan |
| 4613 | Tegaserod maleate | 5-HT4 partial agonist |
| 4590 | Honokiol | Blocks NF-κB activation. Displays anti-inflammatory and antioxidant properties |
| 4583 | Digoxin | Na+, K+-ATPase inhibitor |
| 4581 | Grifolic acid | Selective partial GPR120 agonist |
| 4567 | CCG 50014 | Potent and selective inhibitor of regulator of G-protein signaling 4 (RGS4) |
| 4318 | BX 795 | PDK1 inhibitor |
| 4627 | Phlorizin | Na+-glucose cotransporter inhibitor |
| 4617 | Penitrem A | Potent and selective BK channel blocker |
| 4600 | Auranofin | Thioredoxin reductase inhibitor; induces MPT |
| 4561 | BIBN 4096 | Potent and selective CGRP receptor antagonist |
| 4539 | (R)-(+)-Etomoxir sodium salt | Carnitine palmitoyltransferase I (CPT1) inhibitor |
| 2614 | RWJ 56110 | Selective PAR1 antagonist |
| 4618 | GW 6471 | PPARα antagonist |
| 4599 | 3,5-DHBA | Selective HCA1 agonist |
| 4579 | Pentobarbital sodium salt | Enhances GABAergic activity |
| 4578 | Phenobarbital sodium salt | Enhances GABAergic activity |
| 4577 | LDV FITC | Fluorescent ligand for α4β1 (VLA-4) |
| 4570 | ML 161 | Inhibits PAR1-mediated platelet activation |
| 4525 | Piclamilast | Potent and selective PDE4 inhibitor |
| 4516 | UNC 926 hydrochloride | Binds the MBT domain of L3MBTL1 polycomb protein |
| 4514 | JW 55 | Tankyrase inhibitor; inhibits canonical Wnt signaling |
| 4457 | YE 120 | GPR35 agonist |
| 4445 | PFI 1 | BET bromodomain inhibitor; inhibits BRD2 and BRD4 |
| 4529 | Ciliobrevin A | Hedgehog pathway antagonist; inhibits ciliogenesis |
| 4423 | CHIR 99021 | Highly selective GSK-3 inhibitor |
| 4326 | PhiKan 083 | p53 stabilizing agent |
| 4549 | ML 133 hydrochloride | Kir2.x inhibitor |
| 4517 | NS 2028 | Potent soluble guanylyl cyclase (sGC) inhibitor |